Cover Image
市場調查報告書

新興市場上生物科技企業 (中國、新加坡、巴西、南非、韓國、土耳其、印度、俄羅斯)

Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)

出版商 Kalorama Information 商品編碼 338591
出版日期 內容資訊 英文 36 Pages
訂單完成後即時交付
價格
Back to Top
新興市場上生物科技企業 (中國、新加坡、巴西、南非、韓國、土耳其、印度、俄羅斯) Biotechnology Companies in Emerging Markets (China, Singapore, Brazil, South Africa, South Korea, Turkey, India, Russia)
出版日期: 2015年08月17日 內容資訊: 英文 36 Pages
簡介

生物科技是全球經濟的急速成長市場區隔之一。全球生物科技市場,預計至2025年達到2兆美元。

本報告提供全球新興市場上生物科技市場相關調查,各國的主要企業相關分析。

第1章 摘要整理

第2章 新興市場上生物科技

  • 簡介
  • 主要的新興市場
  • 中國
  • 新加坡
  • 巴西
  • 南非
  • 韓國
  • 土耳其
  • 印度
  • 俄羅斯
  • 近幾年的契約、聯盟,及策略性聯盟

圖表清單

目錄
Product Code: KLI5668767

What's happening in biotechnology in the fastest-growing economies of the world? Who are the leaders operating in these nations and what partnerships have they completed? This report provides answers and informs readers of the companies they need to know about. Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today's biotech market in the countries outside the United States and Europe.

The report identifies eight important emerging company markets and details the biotech market size in these markets. Biotechnology is one of the fastest-growing segments of the world economy. By the year 2025 it has been estimated that the world biotechnology market will reach $2 trillion. By developing biotech, countries lay the groundwork for their own long-term economic growth.

In recent years, investment in U.S. biotech research has been reduced by billions of dollars while at the same time investment in such research in emerging markets has dramatically increased. As a result of this investment, many of these emerging market countries have put in place formal strategies to capitalize on the opportunities such expenditures represent.

This Kalorama Information report, Biotechnology Companies in Emerging Markets, examines the biotech market and notes companies in this market in the following countries:

  • China
  • Singapore
  • Brazil
  • South Africa
  • South Korea
  • Turkey
  • India
  • Russia

Not only is the competition in each market assessed, but significant deals with major global concerns and among companies are detailed. The information presented in this report is the result of data gathered from government reports, company product literature

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • Methodology

TWO: BIOTECHNOLOGY IN EMERGING MARKETS

  • Introduction
  • Selected Emerging Markets
  • China
  • Singapore
  • Brazil
  • South Africa
  • South Korea
  • Turkey
  • India
  • Russia
  • Recent Deals, Partnerships, and Strategic Alliances

LIST OF EXHIBITS

TWO: BIOTECHNOLOGY IN EMERGING MARKETS

  • Table 2-1: Population and GDP by Country: China, Singapore, Brazil, South
  • Africa, South Korea, Turkey, India, Russia
  • Table 2-2: Selected Chinese Biotechnology Companies
  • Table 2-3: Selected Singaporean Biotechnology Companies
  • Table 2-4: Selected Brazilian Biotechnology Companies
  • Table 2-5: Selected South African Biotechnology Companies
  • Table 2-6: Selected South Korean Biotechnology Companies
  • Table 2-7: Selected Turkish Biotechnology Companies
  • Table 2-8: Selected Indian Biotechnology Companies
  • Table 2-9: Selected Russian Biotechnology Companies
  • Table 2-10: Selected Deals, Partnerships, and Strategic Alliances in Emerging Country Markets, 2014 and 2015
Back to Top